C World Wide Group Holding A Cara Therapeutics, Inc. Transaction History

C World Wide Group Holding A

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$12.38 - $29.19 $1.49 Million - $3.5 Million	-120,000 Reduced 17.06%	583,460 $8.33 Million
Q2 2019 Aug 02, 2019	BUY	$17.68 - $21.57 $9.9 Million - $12.1 Million	560,000 Added 390.35%	703,460 $15.1 Million
Q1 2019 May 03, 2019	SELL	$14.41 - $19.64 $140,497 - $191,490	-9,750 Reduced 6.36%	143,460 $2.82 Million
Q4 2018 Feb 12, 2019	SELL	$12.45 - $23.47 $1.17 Million - $2.21 Million	-94,219 Reduced 38.08%	153,210 $1.99 Million
Q3 2018 Nov 05, 2018	SELL	$17.57 - $23.95 $747,093 - $1.02 Million	-42,521 Reduced 14.66%	247,429 $5.93 Million
Q2 2018 Aug 03, 2018	BUY	$11.6 - $19.27 $674,830 - $1.12 Million	58,175 Added 25.1%	289,950 $5.55 Million
Q1 2018 May 03, 2018	SELL	$11.77 - $16.08 $419,494 - $573,107	-35,641 Reduced 13.33%	231,775 $2.87 Million
Q4 2017 Feb 07, 2018	SELL	$11.86 - $14.08 $283,750 - $336,864	-23,925 Reduced 8.21%	267,416 $3.27 Million
Q3 2017 Nov 06, 2017	BUY	$12.6 - $16.34 $3.67 Million - $4.76 Million	291,341	291,341 $3.99 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.